Muh, Carrie R. http://orcid.org/0000-0002-3764-4163
Dorilio, Jessica R. http://orcid.org/0009-0007-3432-8185
Beaudreault, Cameron P. http://orcid.org/0000-0001-5172-8614
McGoldrick, Patricia E. http://orcid.org/0000-0003-3381-0635
Pisapia, Jared M. http://orcid.org/0000-0002-6667-971X
Wolf, Steven M. http://orcid.org/0000-0002-7602-3474
Article History
Received: 2 February 2024
Accepted: 23 February 2024
First Online: 7 March 2024
Declarations
:
: CM reports honoraria from LivaNova and Monteris, participation as a Scientific Advisory Board member for Anuncia, and participation as an investigator in a clinical trial for NeuroPace. SW and PM report honoraria from LivaNova, Eisai, UCB, Sunovion, Greenwich Pharmaceuticals, and participation as investigators in clinical trials for Zogenix, GW Pharma, NeuroPace, Neurelis, UCB, Eisai. SW also reports speaker fees from Marinus. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.